Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease

Ivo Martinovic1, Nico Abegunewardene, Marco Seul

  • 1Department of Heart Surgery, Philipps-University Marburg Medical Center, Mainz, Germany.

Insights

Monocyte chemoattractant protein-1 (MCP-1) is elevated in coronary artery disease (CAD). Elevated MCP-1 levels may indicate inflammatory activity, potentially serving as a marker for atherosclerotic vascular diseases.

Area of Science:

  • Cardiovascular Research
  • Immunology
  • Biochemistry

Background:

  • Monocyte chemoattractant protein-1 (MCP-1) drives monocyte recruitment to the arterial wall, a key process in atherosclerosis.
  • Atherosclerotic vascular diseases, including coronary artery disease (CAD), are significantly influenced by inflammatory processes.

Purpose of the Study:

  • To investigate the association between serum MCP-1 levels and coronary artery disease (CAD).
  • To evaluate MCP-1 as a potential biomarker for inflammatory activity in patients at risk for atherosclerotic diseases.

Main Methods:

  • Serum MCP-1 levels were quantified using sandwich-enzyme-linked immunosorbent assay in 263 volunteers.
  • Coronary risk factors (hypertension, high cholesterol, diabetes, obesity, family history, smoking) were assessed.
  • Soluble adhesion molecules (ICAM-1, E-selectin) were measured as indicators of endothelial activation.

Main Results:

  • Patients with angiographically confirmed CAD exhibited significantly higher MCP-1 serum levels.
  • In patients without CAD, elevated MCP-1 correlated with the number of coronary risk factors.
  • Soluble intercellular adhesion molecule and soluble E-selectin were elevated in patients with CAD or multiple risk factors, suggesting endothelial activation.

Conclusions:

  • Elevated serum MCP-1 levels may serve as a direct indicator of inflammatory activity in patients susceptible to CAD.
  • MCP-1 shows potential as a biomarker for identifying individuals at risk for coronary artery disease and other atherosclerotic vascular conditions.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...